Univest
Univest
  • Markets

Himadri Speciality Chemical Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

  • April 10, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Himadri Speciality Chemical Q4 Results 2026

Himadri Speciality Chemical (NSE: HIMATSEIDE) is preparing to announce its Q4 FY26 financial results for the period ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited statements and consider a final dividend recommendation. With the stock at Rs 420 — against a 52-week high of Rs 620 and 1-year return of -24% — the Q4 FY26 results will be a pivotal event for investors.

Analyst estimates for Q4 FY26 revenue stand at Rs 1,350-1,450 Cr, with PAT expectations of Rs 145-165 Cr and margin projections of EBITDA 16-18%. This article covers the Himadri Speciality Chemical Q4 results 2026 date, earnings estimates, five key performance factors, five risks, analyst ratings, and investor FAQs.

Table of Contents

Toggle
  • Himadri Speciality Chemical Q4 Results 2026 Date
  • Why This Quarter Matters
  • Himadri Speciality Chemical Q4 FY26 Earnings Estimates
  • 5 Key Factors That Will Drive Himadri Speciality Chemical Q4 FY26 Performance
    • Revenue Momentum
    • Margin Trajectory
    • PAT Quality
    • Management Guidance for FY27
    • Dividend Declaration
  • 5 Risks to Watch in Himadri Speciality Chemical Q4 FY26
    • US Tariff and Macro Headwinds
    • Earnings Miss Risk
    • FY27 Guidance Below Consensus
    • FII Outflow Continuation
    • Sector Regulatory Risk
  • Himadri Speciality Chemical Share Price and Analyst Ratings
  • Conclusion
  • Frequently Asked Questions
    • What is the Himadri Speciality Chemical Q4 results 2026 date?
    • What is the Himadri Speciality Chemical Q4 FY26 PAT estimate?
    • What is Himadri Speciality Chemical’s share price ahead of Q4 results?
    • Will Himadri Speciality Chemical declare a dividend in Q4 FY26?
    • Which analysts have a Buy rating on Himadri Speciality Chemical?
    • What were Himadri Speciality Chemical Q3 FY26 results?
    • When do TCS and Infosys announce Q4 results 2026?
    • Is Himadri Speciality Chemical a good investment ahead of Q4 results?
  • Recent Article

Himadri Speciality Chemical Q4 Results 2026 Date

Get free investment predictions and live Q4 result alerts on Univest.

CompanyResults DateArticle
TCSApril 9, 2026Preview on Univest
InfosysApril 23, 2026Preview on Univest
Himadri Speciality ChemicalMay 2026 (Expected)This article

Why This Quarter Matters

Himadri Speciality Chemical enters Q4 FY26 with expectations of 10-14% YoY revenue growth. Q4 determines full-year FY26 performance, sets FY27 estimate baselines, and triggers final dividend announcements. At a 1-year return of -24%, this quarter’s results and FY27 guidance will be critical for determining stock trajectory.

Himadri Speciality Chemical Q4 FY26 Earnings Estimates

Himadri Speciality Chemical Q4 FY26 analyst estimates. Source: MOFSL, YES Securities, JM Financial.

Access premium SEBI-registered research on Univest.

MetricQ3 FY26 ActualQ4 FY26 EstimateDriver
RevenueRs 1,248 CrRs 1,350-1,450 CrVolume + pricing
PATRs 134 CrRs 145-165 CrOperating leverage
MarginEBITDA 16.4%EBITDA 16-18%Cost control
Key Growth MetricQ3 trend10-14% YoY revenue growthManagement execution
Dividend Estimate—Rs 2-4 per shareBoard recommendation

Screen Himadri Speciality Chemical fundamentals on Univest Screener.

5 Key Factors That Will Drive Himadri Speciality Chemical Q4 FY26 Performance

Revenue Momentum

Analysts expect Rs 1,350-1,450 Cr in Q4 FY26 revenue versus Rs 1,248 Cr in Q3. Q4 is seasonally important for the Chemicals sector and the ability to convert the pipeline into recognised revenue will be the first performance test.

Margin Trajectory

Q4 FY26 margin expectations are EBITDA 16-18% versus EBITDA 16.4% in Q3. Input cost trends, employee expenses, and pricing power will determine whether the company can sustain or improve on Q3 levels.

PAT Quality

Net profit is estimated at Rs 145-165 Cr. Investors will assess whether PAT is driven by operational improvement or non-recurring items. A clean recurring profit print is most positively received by institutional investors.

Management Guidance for FY27

The most consequential output will be FY27 guidance — revenue growth bands, margin targets, and capex plans. Credible FY27 guidance carries significant weight for re-rating potential in the current macro environment.

Dividend Declaration

Himadri Speciality Chemical is expected to consider a final dividend of Rs 2-4 per share. The quantum signals management’s confidence in free cash flow generation and sets expectations for FY27 capital allocation.

5 Risks to Watch in Himadri Speciality Chemical Q4 FY26

US Tariff and Macro Headwinds

The 26% US reciprocal tariff on Indian goods has created macro uncertainty. For Himadri Speciality Chemical, indirect impacts include FII outflows and earnings estimate cuts if global demand slows.

Earnings Miss Risk

If Himadri Speciality Chemical’s Q4 FY26 results miss estimates, the stock could correct sharply. Investors should monitor revenue versus Rs 1,350-1,450 Cr and PAT versus Rs 145-165 Cr as the two primary watchpoints.

FY27 Guidance Below Consensus

If FY27 guidance falls below Street expectations, the stock may decline even if Q4 numbers are in line. Forward guidance carries more weight than the reported quarter currently.

FII Outflow Continuation

FIIs sold Rs 22,000 crore in Indian equities in a single week following the tariff announcement. Continued selling creates headwinds for Himadri Speciality Chemical regardless of fundamentals.

Sector Regulatory Risk

The Chemicals sector faces evolving regulatory frameworks. Policy changes that increase compliance costs or alter competitive dynamics could affect Himadri Speciality Chemical’s profitability.

Himadri Speciality Chemical Share Price and Analyst Ratings

Himadri Speciality Chemical share price snapshot and analyst ratings. Source: Brokerages, NSE data.

Himadri Speciality Chemical is trading at Rs 420 as of early April 2026, against a 52-week high of Rs 620 and 52-week low of Rs 360. Market cap stands at Rs 18,800 Cr.

BrokerageRatingTarget PriceThesis
MOFSLBuyRs 580Carbon black + anode material for EV batteries
YES SecuritiesBuyRs 565EV battery graphite anode; lithium ion
JM FinancialAddRs 540Speciality carbon + electrode binder
EmkayBuyRs 550Energy transition chemical; rare franchise

Download the Univest iOS App or Univest Android App to track Himadri Speciality Chemical live and receive real-time Q4 result alerts.

Conclusion

Himadri Speciality Chemical Q4 FY26 results on May 2026 (Expected) will be a key event for Chemicals sector investors. Analysts project PAT of Rs 145-165 Cr and revenue of Rs 1,350-1,450 Cr. At Rs 420 with analyst targets from Rs 550 to Rs 580, FY27 guidance will be the most critical post-results catalyst.

For more Q4 FY26 previews, visit Univest Blogs.

Frequently Asked Questions

What is the Himadri Speciality Chemical Q4 results 2026 date?

The Himadri Speciality Chemical Q4 results 2026 date is May 2026 (Expected). The board will meet to approve audited Q4 FY26 financials and consider a final dividend recommendation.

What is the Himadri Speciality Chemical Q4 FY26 PAT estimate?

Analysts estimate Himadri Speciality Chemical Q4 FY26 PAT at Rs 145-165 Cr, based on revenue of Rs 1,350-1,450 Cr and margin of EBITDA 16-18%.

What is Himadri Speciality Chemical’s share price ahead of Q4 results?

Himadri Speciality Chemical is trading at Rs 420. The 52-week high is Rs 620 and low is Rs 360. The 1-year return is -24% and market cap is Rs 18,800 Cr.

Will Himadri Speciality Chemical declare a dividend in Q4 FY26?

Himadri Speciality Chemical is expected to consider a final dividend of Rs 2-4 per share at the Q4 FY26 board meeting on May 2026 (Expected).

Which analysts have a Buy rating on Himadri Speciality Chemical?

MOFSL (Buy, Rs 580), YES Securities (Buy, Rs 565), JM Financial (Add, Rs 540), Emkay (Buy, Rs 550) have positive ratings heading into Q4 FY26.

What were Himadri Speciality Chemical Q3 FY26 results?

Himadri Speciality Chemical reported Q3 FY26 revenue of Rs 1,248 Cr and PAT of Rs 134 Cr, with margin at EBITDA 16.4%.

When do TCS and Infosys announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026. Infosys Q4 FY26 results are scheduled for April 23, 2026. Read both previews on Univest Blogs.

Is Himadri Speciality Chemical a good investment ahead of Q4 results?

This depends on your risk appetite. Himadri Speciality Chemical has compelling long-term factors alongside genuine near-term risks. Consult a SEBI-registered financial advisor before investing.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only. All financial data and analyst estimates are sourced from publicly available information. Verify before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

UPL Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Zee Entertainment Enterprises Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Sun TV Network Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Sapphire Foods India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Metro Brands Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook



News Q4 Results
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply